Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-23
Page views 419
Article views/downloads 1394
Get Citation

Connect on Social Media

Connect on Social Media

Metastatic non-small-cell lung cancer with EGFR mutation — case report

Marek Jasiówka, Ida Cedrych

Abstract

A case of successful and prolonged treatment of metastatic lung cancer (adenocarcinoma) with the activating mutation of epidermal growth factor receptor gene, treated with erlotinib is presented. A caucasian 79 years old, never-smoker female was diagnosed with stage IV lung cancer in December 2012. A chest CT scan showed tissue mass 6 × 4 cm in size in the right lung with multiple metastases in both lungs. A biopsy revealed a histological subtype adenocarcinoma. As a first line of treatment she received 3 courses of cisplatin and pemetreksed. It was complicated by pulmonary embolism. Progression-free survival after first line treatment was 7 months. Due to disease progression in September 2013 second line treatment with erlotinib was started. First radiological assessment after two months treatment with erlotinib showed partial response of the disease. Patient still continues the treatment with a favourable response and without any adverse reaction.

Article available in PDF format

Purchase Subscription